Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection-Reference-Cited by-同舟云学术

Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection

Published:2007-03 Issue:3 Volume:28 Page:496-504
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Devadas Krishnakumar,Boykins Robert A.,Hewlett Indira K.,Wood Owen L.,Clouse Kathleen A.,Yamada Kenneth M.,Dhawan Subhash

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference42 articles.

1. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice;Agwale;Proc Natl Acad Sci,2002

2. Angiogenic properties of human immunodeficiency virus type 1 Tat protein;Albini;Proc Natl Acad Sci,1995

3. Identification of a novel domain of HIV Tat involved in monocyte chemotaxis;Albini;J Biol Chem,1998

4. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1;Alkhatib;Science,1996

5. Tat protein of human immunodeficiency virus type1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway;Badou;J Virol,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases;Advanced Concepts in Human Immunology: Prospects for Disease Control;2020

2. Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines;PLoS ONE;2014-10-30

3. HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development;International Reviews of Immunology;2009-01

4. Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction;Future HIV Therapy;2008-05